- Tidingo.com

Don't Let 'iPatient' Detract From Hands-On Medicine, Stanford Author/Educator Urges

On his first day as attending physician at Stanford, Abraham Verghese, MD, suggested to the ward team that they leave the "bunker" and head out to their patients' bedsides. "They probably felt that everything I would need to get up to speed on our patients - the necessary images, the laboratory results - was right there in the team room," Verghese wrote in an essay in the Dec.

Worst - 1

1
2
3
4
5

Best - 5

Dnes, 13:00 - Health News from Medical News Today

Hard link

Absence Of CLP Protein Can Be Indicative Of Oral Cancer

Human calmodulin-like protein (CLP) is found in many cell types including breast, thyroid, prostate, kidney, and skin. The protein can regulate many cell activities and has a highly specific expression.

Worst - 1

1
2
3
4
5

Best - 5

Dnes, 13:00 - Health News from Medical News Today

Hard link

U.S. Patent And Trademark Office Accepts Pfizer's Reissue Application On Lipitor Enantiomer Patent

Pfizer Inc announced that the U.S. Patent & Trademark Office has issued a "Notice of Allowance" accepting the company's application to correct the technical defect in the '995 enantiomer patent for atorvastatin calcium, the salt form of atorvastatin sold as Lipitor. The company noted that certain formalities must be completed before the reissue patent will be granted.

Worst - 1

1
2
3
4
5

Best - 5

Dnes, 13:00 - Health News from Medical News Today

Hard link

Target Discovered That Could Ease Spinal Muscular Atrophy Symptoms

There is no cure for spinal muscular atrophy (SMA), a genetic disorder that causes the weakening of muscles and is the leading genetic cause of infant death, but University of Missouri researchers have discovered a new therapeutic target that improves deteriorating skeletal muscle tissue caused by SMA.

Worst - 1

1
2
3
4
5

Best - 5

Dnes, 13:00 - Health News from Medical News Today

Hard link

BASi Receives A European Patent For Culex(R)

BASi is proud to announce the awarding of the new European patent for their Culex® Automated In Vivo Sampling System. The patent is valid until 2019 and is effective in Germany, Denmark, France, UK and Sweden. The Culex Automated In Vivo Sampling System is designed to collect pharmacokinetic and pharmacodynamic (PK/PD) data during the course of drug metabolism experiments.

Worst - 1

1
2
3
4
5

Best - 5

Dnes, 13:00 - Health News from Medical News Today

Hard link

Winter Babies Face Socioeconomic Disadvantages

Many of us may often feel that we've been born under an unlucky sign. Now, new research by a pair of University of Notre Dame economists suggests that some of us are, in fact, born in an unlucky season.

Worst - 1

1
2
3
4
5

Best - 5

Dnes, 13:00 - Health News from Medical News Today

Hard link

Xenomics, Inc. Discusses HPV Screening Test Based On Transrenal DNA Technology At 52nd All India Congress Of Obstetrics & Gynecology

Xenomics, Inc. (XNOM.PK), a developer of non-invasive next-generation molecular diagnostics, announced today that Dr. Samuil Umansky, Chief Scientific Officer, presented at the 52nd All India Congress of Obstetrics & Gynecology (AICOG) in Jaipur, India. Dr.

Worst - 1

1
2
3
4
5

Best - 5

Dnes, 13:00 - Health News from Medical News Today

Hard link

Court Rules In Favor Of Medtronic In Fidelis Litigation

Medtronic, Inc. (NYSE: MDT) reported that on Jan. 5, the United States District Court for the District of Minnesota dismissed with prejudice the Master Consolidated Complaint for Individuals and the Master Consolidated Complaint for Third-Party Payors relating to the multi-district litigation (MDL) involving Medtronic's Sprint Fidelis defibrillator leads on grounds of federal preemption.

Worst - 1

1
2
3
4
5

Best - 5

Dnes, 13:00 - Health News from Medical News Today

Hard link

Human Genomics In China

Ten years ago, the Chinese National Human Genome Center at Shanghai (South Center, hereafter) was established in the Zhangjiang HiTech Park of Pudong District in Shanghai. To commemorate this important event, which marks the beginning of the Genomics Era in China, we specially organize a series of mini-reviews for this special issue.

Worst - 1

1
2
3
4
5

Best - 5

Dnes, 13:00 - Health News from Medical News Today

Hard link

The MDS Foundation Says VIDAZA Approval In Europe Could Provide Survival Benefits To Patients With Myelodysplastic Syndromes And Related Cancers

The Myelodysplastic Syndromes (MDS) Foundation applauds the European Commission's approval of VIDAZA (azacitidine) as an important advance for MDS patients in Europe. Vidaza represents an entirely new approach to treating cancer- it works by epigenetics, that is it helps restore the normal function of genes that regulate cell growth and development.

Worst - 1

1
2
3
4
5

Best - 5

Dnes, 13:00 - Health News from Medical News Today

Latest news

Don't Let 'iPatient' Detract From Hands-On Medicine, Stanford Author/Educator Urges

Absence Of CLP Protein Can Be Indicative Of Oral Cancer

U.S. Patent And Trademark Office Accepts Pfizer's Reissue Application On Lipitor Enantiomer Patent

Target Discovered That Could Ease Spinal Muscular Atrophy Symptoms

BASi Receives A European Patent For Culex(R)

Winter Babies Face Socioeconomic Disadvantages

Xenomics, Inc. Discusses HPV Screening Test Based On Transrenal DNA Technology At 52nd All India Congress Of Obstetrics & Gynecology

Court Rules In Favor Of Medtronic In Fidelis Litigation

Human Genomics In China

The MDS Foundation Says VIDAZA Approval In Europe Could Provide Survival Benefits To Patients With Myelodysplastic Syndromes And Related Cancers

RSS sources

Your own sources

Public sources